French protocol for the diagnosis and management of hereditary angioedema
La Revue de Médecine Interne · 2025
DOI: 10.1016/j.revmed.2025.09.005 ↗Kurz gefasst
Leitlinie in der Zeitschrift La Revue de Médecine Interne, 2025. Verfasst von Isabelle Boccon-Gibod und 17 weiteren Autor:innen. Beteiligte Einrichtung: National reference center for angioedema (CREAK), Internal medicine department, Grenoble University Hospital, Grenoble, France. Hauptthemen laut MEDLINE: Angioedemas, Hereditary. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministère des Solidarités et de la Santé, Ministry of Health and Solidarity.
Abstract (Originalsprache)
Recurrent isolated angioedema (AE) is a diagnostic and therapeutic challenge. Only a rigorous clinical approach can rule out the most obvious diagnoses. The recent international classification recognizes 7 subgroups: mast cells induced AE (spontaneous, allergic), Bradykinin mediated AE (Hereditary or acquired C1Inh; kallikrein-kinin mutations), HAE due to vascular endothelium dysfunction, drug induced AE and AE of unknow origin. Bradykinin-mediated hereditary angioedema (BK-HAE) are rare conditions. The currently accepted incidence of HAE-C1INH is approximately 1 in 50,000 inhabitants per year. Bradykinin is released following activation of the kallikrein/kinin pathway in the vascular lumen and is rapidly degraded by kininases, the main one being angiotensin-converting enzyme. The disease manifests as subcutaneous or submucosal edema. When an attack occurs in the pharynx/larynx area, there is a high risk of asphyxia (25% in the absence of specific treatment). This risk is unpredictable and exists throughout the patient's life. AE can be localized in the abdomen and resemble a surgical emergency. The disease is more symptomatic in women, as estrogen is an aggravating factor. In AE due to C1INH deficiency, the diagnosis is based on the search for a weight and/or functional deficiency in C1 inhibitor. In the forms with normal C1 inhibitor, the diagnosis is solely genetic, such as F12, PLG, or KNG1 mutations. The prognosis for these rare diseases has changed considerably in recent years with the arrival of new, highly effective specific drugs. Patient education is an important part of management. We present here the French protocol for the diagnosis and management of bradykinin-mediated hereditary AE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National reference center for angioedema (CREAK), Internal medicine department, Grenoble University Hospital, Grenoble, France.
- Sorbonne Université, service de médecine interne, AP-HP, Hôpital Saint-Antoine, 75012 Paris, France.
- Department of Anesthesiology and Intensive Care Medicine, Édouard-Herriot Hospital, Hospices Civils de Lyon (HCL), Lyon, France.
- Internal Medicine Department, Édouard-Herriot Hospital, Hospices Civils de Lyon, Lyons, France.
- Department of Internal Medicine, CHU Rouen, Rouen, France.
- University Grenoble Alpes, CHU Grenoble Alpes, Laboratoire d'Immunologie, 38000 Grenoble, France.
Förderung
- Ministère des Solidarités et de la Santé
- Ministry of Health and Solidarity
Zitieren
APA
Boccon-Gibod, I., Fain, O., Gobert, D., Debord, S., Aubineau, M., Ozanne, N., Defendi, F., Gompel, A., Hardy, G., Javaud, N., Lehmann, A., Pagnier, A., Pelletier, F., Bocquet, A., Thanh, A. D., Launay, D., Bouillet, L., & CREAK collaborators (2025). French protocol for the diagnosis and management of hereditary angioedema. La Revue de Médecine Interne. https://doi.org/10.1016/j.revmed.2025.09.005
Vancouver
Boccon-Gibod I, Fain O, Gobert D, Debord S, Aubineau M, Ozanne N, et al. French protocol for the diagnosis and management of hereditary angioedema. La Revue de Médecine Interne. 2025. doi:10.1016/j.revmed.2025.09.005
BibTeX
@article{BocconGibod2025,
author = {Boccon-Gibod, Isabelle and Fain, Olivier and Gobert, Delphine and Debord, Sophie and Aubineau, Magali and Ozanne, Nicolas and Defendi, Federica and Gompel, Anne and Hardy, Gaelle and Javaud, Nicolas and Lehmann, Audrey and Pagnier, Anne and Pelletier, Fabien and Bocquet, Alexis and Thanh, Aurelie Du and Launay, David and Bouillet, Laurence and CREAK collaborators, CREAK collaborators},
title = {French protocol for the diagnosis and management of hereditary angioedema},
journal = {La Revue de Médecine Interne},
year = {2025},
doi = {10.1016/j.revmed.2025.09.005}
}
EUVIMED